FRCPath Haem Part 1 MCQ- Oncology 357

A biopsy from a Hodgkin lymphoma patient shows 9p24.1 amplification, leading to overexpression of PD-L1 and PD-L2. Which therapy exploits this finding?

• Brentuximab
• Rituximab
• Trastuzumab
• Epcoritamab

See All Options

Want to read more?

Subscribe to hematomorph.com to keep reading this exclusive post.

Subscribe Now